A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

clinical trial

start time

end time

November 24, 2022 (4 years 22 days)

Links

Wikidata